NUDT1 and cancer: Recently, the levels and the catalytic activity of MTH1 have been found to be elevated in various cancer cell lines10 and many kinds of clinical specimens, including lung cancer11, brain tumor12–14, renal cancer15, breast cancer16, colorectal cancer17, non-small-cell lung cancer18,19, multiple myeloma20 and esophageal cancer21.